Global In Situ Hybridization Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global In Situ Hybridization Market was valued at $2.0 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 8.8% CAGR, to an estimated market size of $3.1 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The In Situ Hybridization (ISH) market comprises molecular diagnostic techniques, including Fluorescence In Situ Hybridization (FISH) and Chromogenic In Situ Hybridization (CISH), used to detect and localize specific DNA or RNA sequences within preserved tissue sections or cells. This market includes the sale of probes, reagents, automated instruments, and software used for cancer diagnostics, genetic disorder screening, and spatial transcriptomics research.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the In Situ Hybridization Market in the period 2025-30:
- The rising global incidence of cancer and congenital genetic disorders is the primary driver for diagnostic ISH adoption.
- Integration of Artificial Intelligence (AI) and machine learning into digital pathology software is enhancing the accuracy and speed of probe signal interpretation.
- There is a significant shift toward automated hybridization platforms to reduce human error and improve workflow efficiency in high-throughput clinical laboratories.
- The emergence of spatial transcriptomics is driving demand for advanced RNA-based ISH probes in oncology and neuroscience research.
- Increasing adoption of multiplexing capabilities allows for the simultaneous detection of multiple genetic markers within a single tissue sample.
- The growth of precision medicine is fueling the development of ISH-based companion diagnostics for targeted cancer therapies.
- Expansion of molecular cytogenetics in emerging economies is creating new opportunities for manual and cost-effective CISH solutions.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Fluorescence In Situ Hybridization (FISH)
- Chromogenic In Situ Hybridization (CISH)
- Other Technologies & Services